Aimee Wahle

1.5k total citations · 1 hit paper
16 papers, 811 citations indexed

About

Aimee Wahle is a scholar working on Epidemiology, Gastroenterology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aimee Wahle has authored 16 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Gastroenterology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aimee Wahle's work include Gastrointestinal motility and disorders (7 papers), Substance Abuse Treatment and Outcomes (7 papers) and Opioid Use Disorder Treatment (5 papers). Aimee Wahle is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Substance Abuse Treatment and Outcomes (7 papers) and Opioid Use Disorder Treatment (5 papers). Aimee Wahle collaborates with scholars based in United States, Australia and United Kingdom. Aimee Wahle's co-authors include Ryuji Ueno, Raymond M. Panas, Douglas A. Drossman, John F. Johanson, Udi E. Ghitza, Gaurav Sharma, Edward V. Nunes, Li‐Tzy Wu, Abigail G. Matthews and Geetha Subramaniam and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Aimee Wahle

16 papers receiving 784 citations

Hit Papers

Bupropion and Naltrexone in Methamphetamine Use Disorder 2021 2026 2022 2024 2021 40 80 120

Peers

Aimee Wahle
Katharina Beck Switzerland
Kristina T. Phillips United States
Mark Huthwaite New Zealand
Claire Madigan United Kingdom
Melinda F. Davis United States
Sissi V. Pham United States
Tasha Murphy United States
Albena Halpert United States
Aimee Wahle
Citations per year, relative to Aimee Wahle Aimee Wahle (= 1×) peers Jason Ediger

Countries citing papers authored by Aimee Wahle

Since Specialization
Citations

This map shows the geographic impact of Aimee Wahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee Wahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee Wahle more than expected).

Fields of papers citing papers by Aimee Wahle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee Wahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee Wahle. The network helps show where Aimee Wahle may publish in the future.

Co-authorship network of co-authors of Aimee Wahle

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee Wahle. A scholar is included among the top collaborators of Aimee Wahle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee Wahle. Aimee Wahle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
McNeely, Jennifer, Bethany McLeman, Sarah Farkas, et al.. (2023). Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients. Addiction Science & Clinical Practice. 18(1). 56–56. 4 indexed citations
2.
Bunting, Amanda M., Robert P. Schwartz, Li‐Tzy Wu, et al.. (2023). A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool. Journal of Addiction Medicine. 17(4). 471–473. 1 indexed citations
4.
Trivedi, Madhukar H., Robrina Walker, Walter Ling, et al.. (2021). Bupropion and Naltrexone in Methamphetamine Use Disorder. New England Journal of Medicine. 384(2). 140–153. 147 indexed citations breakdown →
5.
McClure, Erin A., Aimee Wahle, Abigail G. Matthews, et al.. (2017). Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug and Alcohol Dependence. 176. 14–20. 10 indexed citations
6.
Schwartz, Robert P., Jennifer McNeely, Li‐Tzy Wu, et al.. (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment. 76. 69–76. 16 indexed citations
7.
McNeely, Jennifer, Li‐Tzy Wu, Geetha Subramaniam, et al.. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine. 165(10). 690–699. 180 indexed citations
8.
Campbell, Aimee, Edward V. Nunes, Abigail G. Matthews, et al.. (2014). Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial. American Journal of Psychiatry. 171(6). 683–690. 182 indexed citations
9.
Weinberg, David V., Aimee Wahle, Michael S. Ip, et al.. (2012). SCORE STUDY REPORT 12. Retina. 33(2). 287–295. 34 indexed citations
10.
Johanson, John F., Douglas A. Drossman, Raymond M. Panas, Aimee Wahle, & Ryuji Ueno. (2008). Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics. 27(8). 685–696. 147 indexed citations
11.
Chey, William D., Richard J. Saad, Raymond M. Panas, Aimee Wahle, & Ryuji Ueno. (2008). M1706 Discontinuation of Lubiprostone Treatment for Irritable Bowel Syndrome with Constipation Is Not Associated with Symptom Increase or Recurrence: Results from a Randomized Withdrawal Study. Gastroenterology. 134(4). A–401. 7 indexed citations
12.
Drossman, Douglas A., William D. Chey, Raymond M. Panas, et al.. (2007). Lubiprostone Significantly Improves Symptom Relief Rates in Adults With Irritable Bowel Syndrome and Constipation (IBS-C): Data from Two Twelve-Week, Randomized, Placebo-Controlled, Double-Blind Trials. Gastroenterology. 132(7). 2586–2587. 29 indexed citations
13.
Ueno, Ryuji, et al.. (2006). Evaluation of Safety and Efficacy in a Twelve-Month Study of Lubiprostone for the Treatment of Chronic Idiopathic Constipation. The American Journal of Gastroenterology. 101. S491–S491. 4 indexed citations
14.
Ueno, Ryuji, et al.. (2006). Pooled Analysis of the Most Frequent Adverse Events Associated with the Use of Lubiprostone. The American Journal of Gastroenterology. 101. S489–S489. 10 indexed citations
15.
Johanson, John F., Aimee Wahle, & Ryuji Ueno. (2006). Efficacy and Safety of Lubiprostone in a Subgroup of Constipation Patients Diagnosed with Irritable Bowel Syndrome with Constipation (IBS-C). The American Journal of Gastroenterology. 101. S491–S491. 4 indexed citations
16.
Ueno, Ryuji, et al.. (2006). Lubiprostone for the Treatment of Chronic Constipation. The American Journal of Gastroenterology. 101. S492–S492. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026